See more : Dalipal Holdings Limited (1921.HK) Income Statement Analysis – Financial Results
Complete financial analysis of 908 Devices Inc. (MASS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of 908 Devices Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- Clinigen Group plc (CLIN.L) Income Statement Analysis – Financial Results
- 3Peak Incorporated (688536.SS) Income Statement Analysis – Financial Results
- Alabama Aircraft Industries, Inc (AAIIQ) Income Statement Analysis – Financial Results
- Pharmaids Pharmaceuticals Limited (PHARMAID.BO) Income Statement Analysis – Financial Results
- Wag! Group Co. (PET) Income Statement Analysis – Financial Results
908 Devices Inc. (MASS)
About 908 Devices Inc.
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 50.23M | 46.85M | 42.21M | 26.89M | 17.97M | 22.05M |
Cost of Revenue | 24.91M | 20.83M | 18.97M | 11.97M | 9.83M | 9.66M |
Gross Profit | 25.32M | 26.02M | 23.23M | 14.92M | 8.14M | 12.39M |
Gross Profit Ratio | 50.41% | 55.54% | 55.05% | 55.49% | 45.31% | 56.19% |
Research & Development | 21.90M | 17.53M | 13.07M | 8.24M | 8.99M | 9.53M |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 46.18M | 43.88M | 32.24M | 12.50M | 11.29M | 9.30M |
Other Expenses | 0.00 | 1.82M | 386.00K | -6.03M | 301.00K | 50.00K |
Operating Expenses | 68.08M | 61.41M | 45.30M | 20.74M | 20.29M | 18.83M |
Cost & Expenses | 92.99M | 82.23M | 64.28M | 32.71M | 30.12M | 28.49M |
Interest Income | 6.48M | 2.03M | 500.00K | 100.00K | 200.00K | 0.00 |
Interest Expense | 201.00K | 129.00K | 486.00K | 976.00K | 1.53M | 1.15M |
Depreciation & Amortization | 2.38M | 1.61M | 925.00K | 831.00K | 900.00K | 896.00K |
EBITDA | -34.03M | -31.82M | -20.94M | -11.01M | -10.94M | -5.49M |
EBITDA Ratio | -67.74% | -75.52% | -51.37% | -44.04% | -60.89% | -24.91% |
Operating Income | -42.76M | -35.38M | -22.07M | -5.82M | -12.14M | -6.44M |
Operating Income Ratio | -85.13% | -75.52% | -52.29% | -21.62% | -67.57% | -29.20% |
Total Other Income/Expenses | 6.15M | 1.82M | -100.00K | -7.00M | -1.23M | -1.10M |
Income Before Tax | -36.61M | -33.56M | -22.17M | -12.82M | -13.37M | -7.54M |
Income Before Tax Ratio | -72.89% | -71.64% | -52.53% | -47.66% | -74.41% | -34.17% |
Income Tax Expense | -211.00K | -1.82M | -53.00K | -5.88M | 1.83M | 50.00K |
Net Income | -36.40M | -31.74M | -22.12M | -6.94M | -15.20M | -7.54M |
Net Income Ratio | -72.47% | -67.75% | -52.40% | -25.79% | -84.60% | -34.17% |
EPS | -1.13 | -1.01 | -0.79 | -0.25 | -0.58 | -0.40 |
EPS Diluted | -1.13 | -1.01 | -0.79 | -0.25 | -0.58 | -0.40 |
Weighted Avg Shares Out | 32.21M | 31.49M | 27.96M | 27.27M | 26.20M | 18.98M |
Weighted Avg Shares Out (Dil) | 32.24M | 31.49M | 27.96M | 27.27M | 26.20M | 18.98M |
908 Devices Inc. (MASS) Q3 2024 Earnings Call Transcript
908 Devices Inc. (MASS) Reports Q3 Loss, Lags Revenue Estimates
908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook
Masivo Silver Commences Drilling Hole Number 7 In Nevada
908 Devices to Participate in Upcoming Investor Conferences
908 Devices to Report Third Quarter 2024 Financial Results on November 12, 2024
Masivo Successfully Drills Hole Number 5 at Promising Skarn Deposit
Masivo Intersects Visible Sulfide Mineralization at Boston Mine Project
908 Devices to Participate in Craig-Hallum Bioprocessing Conference
Masivo Silver Commences Drilling of Third Hole In Nevada
Source: https://incomestatements.info
Category: Stock Reports